-+ 0.00%
-+ 0.00%
-+ 0.00%

Purple Biotech Reports Data At AACR For Colorectal And Head And Neck Cancer

Benzinga·04/28/2025 12:29:45
Listen to the news
  • Activated b-catenin or loss of its negative regulator adenomatous polyposis coli (APC) is a potential biomarker for NT219 in the treatment of colorectal cancer
  • NT219's mechanism of action informs how it can restore efficacy of immunotherapies and expand the patient population that can benefit from immunotherapies